Combination therapy with dexamethasone and osteoprotegerin protects against arthritis-induced bone alterations in antigen-induced arthritis of the rat.
Oelzner
P
P
Department of Internal Medicine III, University Hospital of Jena, Jena, Germany. peter.oelzner@med.uni-jena.de
Fleissner-Richter
S
S
Bräuer
R
R
Hein
G
G
Wolf
G
G
Neumann
T
T
D000818:Animals; D000941:Antigens / Q000008:administration & dosage / Q000009:adverse effects; D001169:Arthritis, Experimental / Q000150:complications*; D001172:Arthritis, Rheumatoid / Q000150:complications*; D001862:Bone Resorption / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D001842:Bone and Bones / Q000000981:diagnostic imaging / Q000473:pathology; D003907:Dexamethasone / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D007719:Knee Joint / Q000000981:diagnostic imaging / Q000187:drug effects / Q000473:pathology; D016328:NF-kappa B / Q000032:analysis / Q000378:metabolism; D053244:Osteoprotegerin / Q000627:therapeutic use*; D053245:RANK Ligand / Q000032:analysis / Q000378:metabolism; D011859:Radiography; D051381:Rats; D011917:Rats, Inbred Lew
D000941:Antigens; D016328:NF-kappa B; D053244:Osteoprotegerin; D053245:RANK Ligand; D003907:Dexamethasone